Sponsor pipeline

Aaron Wolfson clinical trial pipeline

Get alerts when Aaron Wolfson's trials change

1 active trials 1 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-04
Primary completion pushed: 2027-04-15 → 2029-04-15
Primary endpoint(s) modified
Completion pushed: 2030-04-15 → 2034-04-15
NCT05603910 Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation… · Phase 1

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT05603910 Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation… Recurrent Endometrial Carcinoma Recruiting 2026-08-03

Disease areas by active trials

Endometrial Cancer (1)

Get alerts when Aaron Wolfson's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free